157 related articles for article (PubMed ID: 17483696)
1. Brain erythropoietin receptor expression in Alzheimer disease and mild cognitive impairment.
Assaraf MI; Diaz Z; Liberman A; Miller WH; Arvanitakis Z; Li Y; Bennett DA; Schipper HM
J Neuropathol Exp Neurol; 2007 May; 66(5):389-98. PubMed ID: 17483696
[TBL] [Abstract][Full Text] [Related]
2. Glial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment.
Schipper HM; Bennett DA; Liberman A; Bienias JL; Schneider JA; Kelly J; Arvanitakis Z
Neurobiol Aging; 2006 Feb; 27(2):252-61. PubMed ID: 16399210
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of choline acetyltransferase activity in hippocampus and frontal cortex of elderly subjects with mild cognitive impairment.
DeKosky ST; Ikonomovic MD; Styren SD; Beckett L; Wisniewski S; Bennett DA; Cochran EJ; Kordower JH; Mufson EJ
Ann Neurol; 2002 Feb; 51(2):145-55. PubMed ID: 11835370
[TBL] [Abstract][Full Text] [Related]
4. Differential expression of synaptic proteins in the frontal and temporal cortex of elderly subjects with mild cognitive impairment.
Counts SE; Nadeem M; Lad SP; Wuu J; Mufson EJ
J Neuropathol Exp Neurol; 2006 Jun; 65(6):592-601. PubMed ID: 16783169
[TBL] [Abstract][Full Text] [Related]
5. Pathologic and nicotinic receptor binding differences between mild cognitive impairment, Alzheimer disease, and normal aging.
Sabbagh MN; Shah F; Reid RT; Sue L; Connor DJ; Peterson LK; Beach TG
Arch Neurol; 2006 Dec; 63(12):1771-6. PubMed ID: 17172618
[TBL] [Abstract][Full Text] [Related]
6. Loss of nucleus basalis neurons containing trkA immunoreactivity in individuals with mild cognitive impairment and early Alzheimer's disease.
Mufson EJ; Ma SY; Cochran EJ; Bennett DA; Beckett LA; Jaffar S; Saragovi HU; Kordower JH
J Comp Neurol; 2000 Nov; 427(1):19-30. PubMed ID: 11042589
[TBL] [Abstract][Full Text] [Related]
7. Cholinergic plasticity in hippocampus of individuals with mild cognitive impairment: correlation with Alzheimer's neuropathology.
Ikonomovic MD; Mufson EJ; Wuu J; Cochran EJ; Bennett DA; DeKosky ST
J Alzheimers Dis; 2003 Feb; 5(1):39-48. PubMed ID: 12590165
[TBL] [Abstract][Full Text] [Related]
8. Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer disease.
Tremblay C; St-Amour I; Schneider J; Bennett DA; Calon F
J Neuropathol Exp Neurol; 2011 Sep; 70(9):788-98. PubMed ID: 21865887
[TBL] [Abstract][Full Text] [Related]
9. Alpha7 nicotinic receptor up-regulation in cholinergic basal forebrain neurons in Alzheimer disease.
Counts SE; He B; Che S; Ikonomovic MD; DeKosky ST; Ginsberg SD; Mufson EJ
Arch Neurol; 2007 Dec; 64(12):1771-6. PubMed ID: 18071042
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin improves histological and functional outcomes after traumatic brain injury in mice in the absence of the neural erythropoietin receptor.
Xiong Y; Mahmood A; Qu C; Kazmi H; Zhang ZG; Noguchi CT; Schallert T; Chopp M
J Neurotrauma; 2010 Jan; 27(1):205-15. PubMed ID: 19715391
[TBL] [Abstract][Full Text] [Related]
11. Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions.
Bennett DA; Schneider JA; Bienias JL; Evans DA; Wilson RS
Neurology; 2005 Mar; 64(5):834-41. PubMed ID: 15753419
[TBL] [Abstract][Full Text] [Related]
12. Preservation of cortical sortilin protein levels in MCI and Alzheimer's disease.
Mufson EJ; Wuu J; Counts SE; Nykjaer A
Neurosci Lett; 2010 Mar; 471(3):129-33. PubMed ID: 20085800
[TBL] [Abstract][Full Text] [Related]
13. Loss of basal forebrain P75(NTR) immunoreactivity in subjects with mild cognitive impairment and Alzheimer's disease.
Mufson EJ; Ma SY; Dills J; Cochran EJ; Leurgans S; Wuu J; Bennett DA; Jaffar S; Gilmor ML; Levey AI; Kordower JH
J Comp Neurol; 2002 Feb; 443(2):136-53. PubMed ID: 11793352
[TBL] [Abstract][Full Text] [Related]
14. Hippocampal and entorhinal atrophy in mild cognitive impairment: prediction of Alzheimer disease.
Devanand DP; Pradhaban G; Liu X; Khandji A; De Santi S; Segal S; Rusinek H; Pelton GH; Honig LS; Mayeux R; Stern Y; Tabert MH; de Leon MJ
Neurology; 2007 Mar; 68(11):828-36. PubMed ID: 17353470
[TBL] [Abstract][Full Text] [Related]
15. Erythropoietin and erythropoietin receptor in human ischemic/hypoxic brain.
Sirén AL; Knerlich F; Poser W; Gleiter CH; Brück W; Ehrenreich H
Acta Neuropathol; 2001 Mar; 101(3):271-6. PubMed ID: 11307627
[TBL] [Abstract][Full Text] [Related]
16. Preservation of brain nerve growth factor in mild cognitive impairment and Alzheimer disease.
Mufson EJ; Ikonomovic MD; Styren SD; Counts SE; Wuu J; Leurgans S; Bennett DA; Cochran EJ; DeKosky ST
Arch Neurol; 2003 Aug; 60(8):1143-8. PubMed ID: 12925373
[TBL] [Abstract][Full Text] [Related]
17. Expression patterns of erythropoietin and its receptor in the developing midbrain.
Knabe W; Knerlich F; Washausen S; Kietzmann T; Sirén AL; Brunnett G; Kuhn HJ; Ehrenreich H
Anat Embryol (Berl); 2004 Mar; 207(6):503-12. PubMed ID: 14770308
[TBL] [Abstract][Full Text] [Related]
18. Aqueous extract from You-Gui-Yin ameliorates cognitive impairment of chronic renal failure mice through targeting hippocampal CaMKIIα/CREB/BDNF and EPO/EPOR pathways.
Tang Q; Ke H; Wu C; Zeng J; Li Z; Liu Y; Feng S; Xue Q; Xu X
J Ethnopharmacol; 2019 Jul; 239():111925. PubMed ID: 31055001
[TBL] [Abstract][Full Text] [Related]
19. Conversion of mild cognitive impairment to Alzheimer disease predicted by hippocampal atrophy maps.
Apostolova LG; Dutton RA; Dinov ID; Hayashi KM; Toga AW; Cummings JL; Thompson PM
Arch Neurol; 2006 May; 63(5):693-9. PubMed ID: 16682538
[TBL] [Abstract][Full Text] [Related]
20. Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum.
Pillai A; Mahadik SP
J Neurochem; 2006 Sep; 98(5):1411-22. PubMed ID: 16923156
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
